-
EP0876366
European procedure
Extract from the Register of European Patents
EP About this file: EP0876366
| EP0876366 - ANGIOGENESIS INHIBITING PYRIDAZINAMINES [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 31.05.2002 Database last updated on 12.07.2024 | Most recent event Tooltip | 17.04.2015 | Change - lapse in a contracting state | published on 20.05.2015 [2015/21] | Applicant(s) | For all designated states Janssen Pharmaceutica NV Turnhoutseweg 30 2340 Beerse / BE | [N/P] |
| Former [1998/46] | For all designated states JANSSEN PHARMACEUTICA N.V. Turnhoutseweg 30 2340 Beerse / BE | Inventor(s) | 01 /
STOKBROEKX, Raymond, Antoine Janssen Pharmaceutica N.V. Turnhoutseweg 30 B-2340 Beerse / BE | 02 /
VAN DER AA, Marcel, Jozef, Maria Janssen Pharmaceutica N.V. Turnhoutseweg 30 B-2340 Beerse / BE | 03 /
WILLEMS, Marc Janssen Pharmaceutica N.V. Turnhoutseweg 30 B-2340 Beerse / BE | 04 /
MEERPOEL, Lieven Janssen Pharmaceutica N.V. Turnhoutseweg 30 B-2340 Beerse / BE | 05 /
LUYCKX, Marcel, Gerebernus, Maria Janssen Pharmaceutica N.V. Turnhoutseweg 30 B-2340 Beerse / BE | 06 /
TUMAN, Robert, W. Janssen Research Foundation Welsh and McKean Roads Spring House, PA 19477-0776 / US | [1998/46] | Representative(s) | Quaghebeur, Luc, et al Johnson & Johnson Patent Law Department Turnhoutseweg 30 2340 Beerse / BE | [N/P] |
| Former [1998/46] | Quaghebeur, Luc, et al Janssen Pharmaceutica N.V., Patent Department, Turnhoutseweg 30 2340 Beerse / BE | Application number, filing date | 97901059.2 | 14.01.1997 | [1998/46] | WO1997EP00201 | Priority number, date | EP19960200085 | 15.01.1996 Original published format: EP 96200085 | [1998/46] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO9726258 | Date: | 24.07.1997 | Language: | EN | [1997/32] | Type: | A2 Application without search report | No.: | EP0876366 | Date: | 11.11.1998 | Language: | EN | The application published by WIPO in one of the EPO official languages on 24.07.1997 takes the place of the publication of the European patent application. | [1998/46] | Type: | B1 Patent specification | No.: | EP0876366 | Date: | 25.07.2001 | Language: | EN | [2001/30] | Search report(s) | Classification | IPC: | C07D417/04, A61K31/50 | [1998/46] | CPC: |
C07D417/04 (EP,KR,US);
A61K31/50 (KR);
A61P9/00 (EP);
C07D417/14 (EP,US)
| Designated contracting states | AT, BE, CH, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, NL, PT, SE [1998/46] | Extension states | LT | 17.08.1998 | LV | 17.08.1998 | RO | 17.08.1998 | SI | 17.08.1998 | Title | German: | ANGIOGENESIS HEMMENDE PYRIDAZINAMINE | [1998/46] | English: | ANGIOGENESIS INHIBITING PYRIDAZINAMINES | [1998/46] | French: | PYRIDAZINAMINES INHIBANT L'ANGIOGENESE | [1998/46] | Entry into regional phase | 17.08.1998 | National basic fee paid | 17.08.1998 | Designation fee(s) paid | 17.08.1998 | Examination fee paid | Examination procedure | 19.06.1997 | Request for preliminary examination filed International Preliminary Examining Authority: EP | 17.08.1998 | Examination requested [1998/46] | 08.08.2000 | Despatch of communication of intention to grant (Approval: Yes) | 08.12.2000 | Communication of intention to grant the patent | 19.03.2001 | Fee for grant paid | 19.03.2001 | Fee for publishing/printing paid | Opposition(s) | 26.04.2002 | No opposition filed within time limit [2002/29] | Fees paid | Renewal fee | 01.02.1999 | Renewal fee patent year 03 | 31.01.2000 | Renewal fee patent year 04 | 31.01.2001 | Renewal fee patent year 05 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | |||
| Former [2002/18] | FR | 21.12.2001 | Cited in | International search | [A]EP0398427 (JANSSEN PHARMACEUTICA NV [BE]) [A] 1,10* the whole document *; | [A]EP0429344 (SANOFI SA [FR]) [A] 1,10 * the whole document *; | [AD]EP0435381 (JANSSEN PHARMACEUTICA NV [BE]) [AD] 1,10 * the whole document * |